Skip to main navigation Skip to search Skip to main content

Idiopathic pulmonary fibrosis and gastroesophageal reflux

  • Filippo Patrucco
  • , Ludovica Venezia
  • , Roberta Nicali
  • , Rinaldo Pellicano
  • , Mattia Bellan
  • , Piero E. Balbo

Research output: Contribution to journalReview articlepeer-review

Abstract

Idiopathic pulmonary fibrosis (IPF) is a rare and progressive chronic respiratory disease. Although interconnections between gastroesophageal reflux disease (GERD) and IPF are numerous, their relationship is still controversial. Pathogenetic hypotheses involve micro-aspiration of gastric acid causing inflammation and then remodeling of lung structure until fibrosis, even to acute accelerating exacerbations of IPF. Moreover, IPF may itself aggravate GERD increasing intrathoracic pressure. Several studies have evaluated the possible beneficial effects of antacid and antireflux therapies on patients' outcomes and pulmonary function, but results are still conflicting. This narrative review explores many aspects of the relationship between IPF and GERD, including pathogenesis, clinical implications, medical and surgical GERD therapies, summarizing the results of most important studies conducted in this specific field.

Original languageEnglish
Pages (from-to)12-19
Number of pages8
JournalMinerva Pneumologica
Volume59
Issue number1
DOIs
Publication statusPublished - Mar 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Antireflux therapy
  • Gastroesophageal reflux
  • Idiopathic pulmonary fibrosis

Fingerprint

Dive into the research topics of 'Idiopathic pulmonary fibrosis and gastroesophageal reflux'. Together they form a unique fingerprint.

Cite this